WebApr 3, 2024 · Höglinger GU, Respondek G, Stamelou M, et al; Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2024;32(6):853-864. doi:10.1002/mds.26987 PubMed Google Scholar Crossref WebHere, we propose official MDS clinical diagnostic criteria for PSP (MDS-PSP criteria) for use in research and clinical practice. Methodology of Criteria Generation The MDS-PSP …
Frontiers The Burden of Progressive Supranuclear Palsy on …
WebJul 12, 2024 · Progressive supranuclear palsy (PSP) is a neurodegenerative disease and common cause of atypical parkinsonism, with an estimated prevalence of 5 to 7 per 100,000. 1 The neuropathology of PSP, the gold standard for diagnosis, is centred on the structural microtubule-associated protein tau, encoded by the MAPT gene. 2 WebJul 31, 2024 · The MDS-PSP criteria work well for retrospective allocation to PSP subgroups and were more suitable for identification of PSP in comparison to the former NINDS-SPSP … taten des augustus
Cognitive and behavioral profile of progressive supranuclear palsy …
WebThe criteria for probable PSP are highly specific, making them suitable for therapeutic, analytic epidemiologic, and biologic studies, but not very sensitive. The criteria for possible PSP are substantially sensitive, making them suitable for descriptive epidemiologic studies, but less specific. WebThe Movement Disorders Society PSP diagnostic criteria include syndromes with few or mild symptoms that are suggestive of underlying PSP pathology and could provide an opportunity for earlier therapeutic interventions in the future. WebBackground Recent diagnostic criteria for progressive supranuclear palsy (PSP) by the Movement Disorder Society (MDS) operationalise recently recognised subtypes, beyond the ‘classical’ Richardson phenotype (PSP-RS): predominant parkinsonism (PSP-P), predominant gait freezing (PSP-PGF), and frontal-cognitive- behavioural presentations (PSP-F). tatenda magetsi